|
|
| | SANGIVAMYCIN Basic information |
| Product Name: | SANGIVAMYCIN | | Synonyms: | 7-DEAZAADENOSINE-7-CARBOXAMIDE;7-DEAZA-7-CARBAMOYLADENOSINE;ski27013;NSC-65346;SANGIVAMYCIN;4-AMINO-7-(BETA-D-RIBOFURANOSYL)PYRROLO[2,3-D]PYRIMIDINE-5-CARBOXAMIDE;sangivamycin hydrate from streptomyces rimosus;Antibiotic BA-90912 | | CAS: | 18417-89-5 | | MF: | C12H15N5O5 | | MW: | 309.28 | | EINECS: | | | Product Categories: | | | Mol File: | 18417-89-5.mol |  |
| | SANGIVAMYCIN Chemical Properties |
| Melting point | 260°C | | Boiling point | 449.56°C (rough estimate) | | density | 1.3120 (rough estimate) | | refractive index | 1.6500 (estimate) | | storage temp. | 2-8°C | | solubility | 0.5 M HCl: complete5 mg/ml | | pka | 12.38±0.70(Predicted) | | form | White solid | | Stability: | Hygroscopic |
| Hazard Codes | T+ | | Risk Statements | 26/27/28 | | Safety Statements | 36/37/39-45 | | RIDADR | UN 2811 6.1/PG 2 | | WGK Germany | 3 | | RTECS | UY9355000 |
| | SANGIVAMYCIN Usage And Synthesis |
| Uses | Sangivamycin is a cytotoxic purine nucleoside. | | Definition | ChEBI: A nucleoside analogue that is adenosine in which the nitrogen at position 7 is replaced by a carbamoyl-substituted carbon. It is a potent inhibitor of protein kinase C. |
| | SANGIVAMYCIN Preparation Products And Raw materials |
|